The Patent Finder

Bionor Immuno As

Also on record
Records under this name other than the patents Bionor Immuno As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Bionor Immuno As

PatentTitleStatus Expires Confidence
US 9,925,691Drill bit
Lapsed on the fee record
Ended Mar 27, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2026From the USPTO record
US 9,493,514Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes
Lapsed on the fee record
Ended Nov 15, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 15, 2024From the USPTO record
US 10,449,245Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
Lapsed on the fee record
Ended Oct 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 22, 2023From the USPTO record
US 10,143,737Method for the vaccination against HIV
Lapsed on the fee record
Ended Dec 4, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 4, 2022From the USPTO record
US 10,124,059Dimeric scaffold peptides comprising HIV-1 GP120 and GP41 epitopes
Lapsed on the fee record
Ended Nov 13, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 13, 2022From the USPTO record
US 6,706,859HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
Term ended
Term ended Nov 3, 2020 · From the USPTO record
Term endedTerm ended Nov 3, 2020From the USPTO record
US 7,311,915Method of producing an HIV-1 immune response
Lapsed on the fee record
Ended Dec 25, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 25, 2019From the USPTO record
US 9,200,065Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain
Lapsed on the fee record
Ended Dec 1, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 1, 2019From the USPTO record
US 7,709,003Method of producing an HIV-1 immune response
Lapsed on the fee record
Ended May 4, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2018From the USPTO record
US 7,709,004Method of producing an HIV-1 immune response
Lapsed on the fee record
Ended May 4, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 4, 2018From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited